FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

789073003: Product containing cilastatin and imipenem and relebactam (medicinal product)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3786624015 Product containing cilastatin and imipenem and relebactam (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3786625019 Cilastatin- and imipenem- and relebactam-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3786624015 Product containing cilastatin and imipenem and relebactam (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3786625019 Cilastatin- and imipenem- and relebactam-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cilastatin- and imipenem- and relebactam-containing product Is a Product containing beta-lactamase inhibitor (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin- and imipenem- and relebactam-containing product Plays role Antibacterial therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin- and imipenem- and relebactam-containing product Is a Cilastatin- and imipenem-containing product true Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin- and imipenem- and relebactam-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Cilastatin true Inferred relationship Existential restriction modifier (core metadata concept) 3
Cilastatin- and imipenem- and relebactam-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Imipenem true Inferred relationship Existential restriction modifier (core metadata concept) 1
Cilastatin- and imipenem- and relebactam-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Relebactam (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Cilastatin- and imipenem- and relebactam-containing product Is a Medicinal product containing beta-lactamase inhibitor and acting as antibacterial agent (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only cilastatin and imipenem and relebactam (medicinal product) Is a True Cilastatin- and imipenem- and relebactam-containing product Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form Is a True Cilastatin- and imipenem- and relebactam-containing product Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start